India will provide financing for new plants; Cispharma NJ plant gets warning letter;

> The FDA has issued a warning letter to the Cispharma plant in Cranbury, NJ. More

> The FDA says that a U.K. man has been sentenced to 18 months in prison and fined $800,000 for distributing adulterated cancer drugs to physicians in the U.S. Release

> The Export-Import Bank of India said it would provide financing to Indian drugmakers to build FDA-compliant drug manufacturing plants. Report

> The FDA is proposing a new rule that would allow mail inspectors to hold drugs they believe may be misbranded or adulterated. Item (PDF)

> India's Competition Commission has started a study of drug manufacturing and other costs in hopes of leading to cheaper drug prices. Report

> The European Medicines Agency (EMA) says it has finalized guidelines on the use of certain starting materials in nonrecombinant biological drugs which call for manufacturers to "clearly define" where the manufacturing process starts and should include information that describes the manufacturing process and process controls. Report

> The EFPIA will use cloud-based software to verify the authenticity of drugs as part of the EU Falsified Medicines Directive. Report

> Some Indian manufacturers of pharma equipment are asking the government to add tariffs to equipment imported from China. Story

And Finally... The FDA is looking for better ways to communicate about how healthcare providers should respond when counterfeit drugs are discovered in the U.S. More